The NHANES data used in this analysis are publicly available on-line from the Centers for Disease Control and Prevention (<http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm>). A public-use version of the CRELES data is available from the Inter-University Consortium for Political and Social Research (ICPSR) database (<http://doi.org/10.3886/ICPSR31263.v1>). Data on leukocyte telomere length and survival follow-up are not currently included in the public-use data because data collection and processing is still in progress. We have included, in Supplementary Material, a minimal dataset for CRELES that includes the data necessary to replicate our findings. A public-use version of the SEBAS data which does not include the date of death or the date of the SEBAS interview is available from the ICPSR database (<http://doi.org/10.3886/ICPSR03792.v7>). The date of death comes from the parent survey, the Taiwan Longitudinal Study of Aging (TLSA), conducted by the Surveillance and Health Research Division of the Health Promotion Administration (HPA) at the Ministry of Health and Welfare in Taiwan. Requests for these data can be sent to Yu-Hsuan Lin (<yuhsuanl@hpa.gov.tw>).

Introduction {#sec001}
============

Human telomeres shorten with age in leukocytes as well as in other tissues \[[@pone.0152486.ref001]\]. Thus, telomere length has generated substantial interest as a potential predictor of age-related diseases and mortality. A number of studies that examined the association between leukocyte telomere length (LTL) and all-cause mortality found a statistically discernible relationship \[[@pone.0152486.ref002]--[@pone.0152486.ref014]\], but few studies explicitly compared LTL with other predictors of mortality: three \[[@pone.0152486.ref009], [@pone.0152486.ref015], [@pone.0152486.ref016]\] compared LTL with other biomarkers, and one \[[@pone.0152486.ref017]\] compared LTL with both biomarker and other predictors. These four studies \[[@pone.0152486.ref009], [@pone.0152486.ref015]--[@pone.0152486.ref017]\] focused on effect sizes and/or the significance of LTL; none quantified the discriminatory ability of LTL and compared it with a range of established mortality predictors such as those included in existing prognostic indexes \[[@pone.0152486.ref018]\]. A further limitation of these four studies is that they were based on samples of very old individuals and in one case \[[@pone.0152486.ref017]\] drew from a clinical population of discharged hospital patients. Unlike this investigation, none was based on a nationally-representative sample including cohorts young enough to have only minimal bias from selective mortality.

Telomeres---the repetitive DNA sequences that cap the chromosomes to protect them from fusion and degradation---shorten with each cell division \[[@pone.0152486.ref019]\]. Eventually, they reach a critical minimum length, triggering the cell to stop dividing \[[@pone.0152486.ref020]\]. Thus at the cellular level, telomeres act as a 'molecular clock', but to what extent they explain organismal aging---or mortality---is debatable \[[@pone.0152486.ref021], [@pone.0152486.ref022]\]. Some suggest that cell senescence triggered by telomere dysfunction contributes to the decline in tissue function we associate with aging \[[@pone.0152486.ref023]\]. Indirect evidence supports this view: some genetic diseases associated with premature aging also lead to telomere shortening \[[@pone.0152486.ref024], [@pone.0152486.ref025]\], and genetically modified mice with short telomeres manifest symptoms reminiscent of human aging \[[@pone.0152486.ref024]\]. Genetic variance studies have also identified several genetic markers that are associated with both telomere length and various age-related diseases or mortality \[[@pone.0152486.ref026], [@pone.0152486.ref027]\]. Thus, LTL has gained popularity as a marker of aging. Yet, a rigorous comparison of the ability of LTL versus well-established predictors to discriminate decedents from survivors is lacking.

Our study focuses on all-cause mortality. Mortality is an attractive metric of aging because death is a well-defined and salient outcome with minimal measurement error when vital status is determined from virtually complete death registration records. Prior evidence regarding the relationship between LTL and mortality has been mixed. Telomere length was found to be longer in a high longevity region of Costa Rica as compared to the rest of the country \[[@pone.0152486.ref028]\]. While some studies have reported an inverse association between LTL and all-cause mortality \[[@pone.0152486.ref002]--[@pone.0152486.ref014]\]; others have found no relationship \[[@pone.0152486.ref015]--[@pone.0152486.ref017], [@pone.0152486.ref029]--[@pone.0152486.ref037]\] or only a marginally significant association \[[@pone.0152486.ref038], [@pone.0152486.ref039]\]. Recently, the largest study to date \[[@pone.0152486.ref008]\] reported an association between short LTL and mortality, including cancer mortality, although genetically-determined short telomeres were protective of cancer mortality. Thus, the relationship between shorter telomeres and mortality appears to be a complex one, potentially confounded by multiple factors, and causal linkages have not been established \[[@pone.0152486.ref007]\]. Here we pose a more fundamental question: can LTL predict mortality better than other well-established and less costly predictors?

Many studies of LTL and mortality focus on the significance of the association, but statistical significance is not a sufficient criterion to evaluate the incremental value of a marker. Similarly, the effect size or magnitude of the association (e.g., a hazard ratio) is useful for identifying risk factors, but it is not an appropriate statistical tool for quantifying predictive accuracy because even strong associations (e.g., large hazard ratios) may yield little improvement in discrimination \[[@pone.0152486.ref040], [@pone.0152486.ref041]\]. For example, a large and significant hazard ratio associated with extreme values of a particular biomarker may not distinguish well between survivors and decedents in a statistical model if very few people have such extreme values of the biomarker. In contrast to previous approaches, here we quantify the prognostic or discriminatory value of LTL for predicting five-year all-cause mortality in terms of its ability to differentiate between decedents and survivors compared with 21 well-established predictors of mortality. We use data from nationally representative samples of older persons in Costa Rica (ages 61+), Taiwan (ages 54+), and the U.S. (ages 60+).

Materials and Methods {#sec002}
=====================

Data {#sec003}
----

Data come from the second wave (fielded in 2006--08) of the Costa Rican Study on Longevity and Healthy Aging (CRELES), the 1999--2002 waves of the National Health and Nutrition Examination Survey (NHANES), and the 2000 wave of the Social Environment and Biomarkers of Aging Study (SEBAS). Details regarding sampling design and response rates for each dataset are provided elsewhere \[[@pone.0152486.ref042]--[@pone.0152486.ref044]\].

Among 2364 respondents aged 61 and older who completed the CRELES wave 2 interview, 2166 provided a blood sample from which DNA was extracted and banked. A subsample (*N =* 994) of these respondents was selected for the LTL assay, including all those from the Nicoya region and a probability sample of the remainder. The concentration of the stored DNA specimen was insufficient for 71 of those selected, leaving an analysis sample of 923.

For NHANES, we restricted the analysis to persons aged 60 and older (for comparability with the other samples and to allow for the inclusion of cognitive function, which was not asked of respondents younger than 60), among whom 3706 completed the interview, 3234 participated in the exam, and 3068 were eligible for blood sampling. Of those eligible, the analysis sample comprised 2672 individuals who supplied a DNA specimen.

Among 1497 respondents aged 54 and older who completed the 2000 SEBAS household interview, 1386 were eligible for the exam and 111 were ineligible because of a health condition. Of those eligible, 363 refused the exam and 47 had insufficient DNA, leaving an analysis sample of 976.

Ethics Statements {#sec004}
-----------------

All three surveys obtained written, informed consent from all participants and received human subjects approval from the institutional review boards (IRB) at the institutions conducting the studies: the Ethical Science Committee of the University of Costa Rica (VI-763-CEC-23-04) \[CRELES\]; Princeton University IRB (\#1848, \#2193, \#2791, \#3391), Georgetown University IRB (\#1999--195), and the Joint IRB in Taiwan (NIFP-IRB-2000-01) \[SEBAS\]; NCHS Research Ethics Review Board (Protocol \#98--12) \[NHANES\].

Mortality {#sec005}
---------

Survival status was determined based on administrative records and in the case of CRELES, complementary survey follow-up (see [S1 Appendix](#pone.0152486.s001){ref-type="supplementary-material"}). The number of respondents who died within five years was 276 in CRELES, 442 in NHANES, and 128 in SEBAS.

Predictors {#sec006}
----------

LTL was measured using quantitative polymerase chain reaction (Q-PCR) to determine the relative ratio of telomere to a single-copy gene (T/S ratio) in all three studies, although there were some differences in the assay protocol (see [S1 Appendix](#pone.0152486.s001){ref-type="supplementary-material"}). The three datasets were analyzed independently (e.g., LTL values from the three studies were not pooled). The inter-assay coefficients of variation for the three studies were: 3.7% for CRELES, 6.5% for NHANES, and 7% for SEBAS.

Within each study, we tested LTL against a broad set of well-established predictors of mortality, many of which are used in existing prognostic indexes (eprognosis.ucsf.edu). They comprise two demographic variables (age, sex), three social factors (marital status, education, and social integration), two health behaviors (smoking, physical activity), six self-reported measures of health status (global self-assessed health, activities of daily living (ADL) limitations, mobility limitations, history of diabetes, history of cancer, and number of hospital days/stays in the past 12 months), a cognitive assessment, and seven biomarkers (systolic and diastolic blood pressure, total cholesterol, glycosylated hemoglobin, body mass index, C-reactive protein, and serum creatinine) in addition to LTL. See [Table 1](#pone.0152486.t001){ref-type="table"} for details.

10.1371/journal.pone.0152486.t001

###### Potential predictors included in the analysis.
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                                                                             Costa Rica \[CRELES\]                                                                                                                                                                         Taiwan \[SEBAS\]                                                                                                                                                                                                                                                U.S. \[NHANES\]
  -------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------
  **Demographic characteristics**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  1\) Age at exam                                                            61+                                                                                                                                                                                           54+                                                                                                                                                                                                                                                             60+
  2\) Sex                                                                    Male, Female                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  **Social factors**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  3\) Marital status                                                         Categorical: Married/partner; Widowed; Divorced/separated; Never married                                                                                                                                                                                                                                                                                                                                                                                      
  4\) Education[^a^](#t001fn002){ref-type="table-fn"}                        Completed Years                                                                                                                                                                               Completed Years                                                                                                                                                                                                                                                 Categorical
   Very low                                                                  None                                                                                                                                                                                          None                                                                                                                                                                                                                                                            Less than 9th grade
   Low                                                                       1--2 years                                                                                                                                                                                    1--5 years                                                                                                                                                                                                                                                      9th-- 11th grade
   Medium                                                                    3--5 years                                                                                                                                                                                    6 years                                                                                                                                                                                                                                                         High school diploma/GED
   High                                                                      6--9 years                                                                                                                                                                                    7--11 years                                                                                                                                                                                                                                                     Some college or associate degree
   Very high                                                                 10+ years                                                                                                                                                                                     12+ years                                                                                                                                                                                                                                                       College graduate or higher
  5\) Social integration index[^b^](#t001fn003){ref-type="table-fn"}         Based on 5 items; Cronbach's α = 0.58                                                                                                                                                         Based on 11 items; Cronbach's α = 0.73                                                                                                                                                                                                                          Based on 3 items; Cronbach's α = 0.72
  **Health behaviors**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  6\) Smoking status                                                         Categorical: Never; Former Smoker; Current Smoker                                                                                                                                                                                                                                                                                                                                                                                                             
  7\) Exercise frequency                                                     Dummy: Exercised 3+ times per week in past 12 months                                                                                                                                          Categorical: None; \<3 times per week; 3--5 times per week; 6+ times per week                                                                                                                                                                                   Cumulative frequency of moderate/vigorous leisure-time physical activities in past 30 days, recoded: None; \<12, 12--29, 30+
  **Health status (self-reported)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  8\) Self-assessed health status                                            Based on a simple question that is typically worded: "How would you rate your overall health?" and has five response categories ranging from "poor" to "excellent."                                                                                                                                                                                                                                                                                           
  9\) Number of ADL limitations[^c^](#t001fn005){ref-type="table-fn"}        Based on 5 ADLs                                                                                                                                                                               Based on 6 ADLs                                                                                                                                                                                                                                                 Based on 5 ADLs
  10\) Index of mobility limitations[^d^](#t001fn006){ref-type="table-fn"}   Based on 4 physical tasks; coded on a 3-point scale from no difficulty to unable                                                                                                              Based on 8 physical tasks; coded on a 4-point scale from no difficulty to unable                                                                                                                                                                                Based on 8 physical tasks; coded on a 4-point scale from no difficulty to unable
  11\) History of diabetes                                                   Doctor told you that you have...                                                                                                                                                              Ever had...                                                                                                                                                                                                                                                     Ever told by a doctor...
  12\) History of cancer                                                     Doctor told you that you have...                                                                                                                                                              Ever had...                                                                                                                                                                                                                                                     Ever told by a doctor...
  13\) Hospital days/stays, past 12 months                                   Days                                                                                                                                                                                          Stays                                                                                                                                                                                                                                                           Stays
  **Interviewer-administered assessment**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  14\) Cognitive function[^e^](#t001fn008){ref-type="table-fn"}              Based on tasks from the MMSE \[[@pone.0152486.ref045]\] (basic orientation, immediate & delayed recall, follow a 3-stage command, copy a geometric design) as well as a reverse recall task   Based on several items from the SPMSQ \[[@pone.0152486.ref046]\] (basic orientation, serial subtraction), a word recall task from the modified RAVLT \[[@pone.0152486.ref047]\], & a modified version of the Digits Backwards Test \[[@pone.0152486.ref048]\]   WAIS III (Wechsler Adult Intelligence Scale, Third Edition) Digit Symbol Substitution Test \[[@pone.0152486.ref049], [@pone.0152486.ref050]\]
  **Biomarkers**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  15\) Systolic blood pressure (SBP)                                         Mean of 1st & 2nd readings taken at home                                                                                                                                                      Mean of 1st & 2nd readings taken in the hospital                                                                                                                                                                                                                Mean of 1st & 2nd readings taken in the Mobile Exam Center (MEC)
  16\) Diastolic blood pressure (DBP)                                        Mean of 1st & 2nd readings (at home)                                                                                                                                                          Mean of 1st & 2nd readings (in hospital)                                                                                                                                                                                                                        Mean of 1st & 2nd readings (MEC)
  17\) Total cholesterol (TC)                                                Metabolic risk factor associated with cardiovascular disease                                                                                                                                                                                                                                                                                                                                                                                                  
  18\) Glycosylated hemoglobin (HbA1c)                                       Marker of glucose metabolism                                                                                                                                                                                                                                                                                                                                                                                                                                  
  19\) Body mass index (BMI)                                                 Measure of body fat computed as body weight (in kg) divided by height (in m) squared                                                                                                                                                                                                                                                                                                                                                                          
  20\) C-reactive protein (CRP)                                              Inflammatory marker                                                                                                                                                                                                                                                                                                                                                                                                                                           
  21\) Serum creatinine (SCr)                                                Marker of renal function                                                                                                                                                                                                                                                                                                                                                                                                                                      
  22\) Leukocyte telomere length (LTL)                                       Measured by the relative ratio of telomere to a single-copy gene (T/S ratio)                                                                                                                                                                                                                                                                                                                                                                                  

Abbreviations: ADL, Activities of Daily Living; MMSE, Mini-Mental State Exam; RAVLT, Rey Auditory Verbal Learning Test; SPMSQ, Short Portable Mental Status Questionnaire.

^a^ Because education was coded in five categories for NHANES, we recoded education (completed years) into categories for CRELES and SEBAS as well.

^b^ See [S1 Table](#pone.0152486.s010){ref-type="supplementary-material"} for a detailed list of the components included in the social integration index for each country.

Because the level of measurement varied across items, we standardized each of the components (based on the within-country distribution) and then calculated the mean across valid items if at least 75% items were valid.

^c^ ADLs included: eating; getting out of bed; moving around the house; bathing (CRELES, SEBAS); dressing (NHANES, SEBAS); standing up from a chair (NHANES); using the toilet (CRELES, SEBAS).

^d^ The index was based on difficulty performing various physical tasks without assistance.

Three of the tasks were asked in all three surveys (walking, climbing stairs, reaching overhead), although CRELES asked respondents to demonstrate whether they could lift their arms above their shoulders whereas the other two surveys relied on self-report. The fourth task differed across surveys: pushing/pulling large objects (CRELES), sitting for a long period (NHANES), and running a short distance (SEBAS). NHANES and SEBAS included four additional tasks that were not asked in CRELES: standing for an extended period, lifting or carrying something somewhat heavy, grasping an object with her/his fingers, and bending/kneeling/squatting. Based on the recommendations of Long & Pavalko \[[@pone.0152486.ref051]\], we constructed the index by summing the available items (potential range: 0--8 in CRELES; 0--24 in NHANES and SEBAS), adding a constant (0.5), and taking the logarithm of the result, which allows for relative rather than absolute effects.

^e^ The summary measure of cognitive function is based on the respondent's ability to perform various tasks administered by the interviewer.

Statistical Analysis {#sec007}
--------------------

A substantial portion of each sample was missing data for at least one predictor. To maximize use of the data, we followed standard practices of multiple imputation (see [S1 Appendix](#pone.0152486.s001){ref-type="supplementary-material"}). Descriptive statistics were weighted to account for oversampling and differential response rates ([S2 Table](#pone.0152486.s011){ref-type="supplementary-material"}). All models were fitted separately by country using a Cox hazards model with unweighted data. To quantify the predictive ability of each variable, we used the Area Under the Receiver Operating Characteristic Curve (AUC), a commonly used measure of discrimination with values ranging from 0 to 1, where 0.5 indicates the model performs no better than chance and 1.0 represents perfect accuracy. The AUC can be interpreted as the probability that the model predicts a higher probability of death for those who died than for those who survived \[[@pone.0152486.ref052]\]. Pencina et al. \[[@pone.0152486.ref040]\] suggest that an increase of 0.01 in the AUC is a meaningful improvement.

We first tested each predictor individually using duration of follow-up as the metric for time. Education, exercise frequency, and self-assessed health status were treated as categorical in order to allow for non-linear effects. We tested each predictor for non-proportional hazards (i.e., effect of the predictor varies with duration of follow-up). In cases where the interaction between the predictor and duration was significant (*p*\<0.05), we included that interaction in the model. In CRELES, the effects of marital status, exercise frequency, systolic blood pressure, and C-reactive protein diminished with time. For NHANES, the effect of diabetes weakened over time. There was no evidence of non-proportional hazards in SEBAS.

Next, we ran models that controlled for age (i.e., using age as the time metric so as to estimate age-specific mortality) and tested each of the remaining 21 predictors individually. To allow for non-proportional hazards (i.e., effect of the predictor varies across age), we tested an interaction between each predictor and age. We included in the final model interactions that were significant: sex, social integration, C-reactive protein, and serum creatinine for SEBAS; marital status, social integration, and exercise frequency for NHANES; but none for CRELES.

Our final models controlled for both age (as the clock) and sex. These models tested the incremental contribution for each of the remaining 20 predictors individually. Again, we included the interactions with age noted above.

Results {#sec008}
=======

When the 22 variables were tested individually, chronological age was, by far, the single best predictor of five-year mortality (AUC = 0.78 in Costa Rica, 0.74 in Taiwan, and 0.71 in the U.S.; [Table 2](#pone.0152486.t002){ref-type="table"}). Although LTL was significantly associated with mortality in all three countries ([Table 3](#pone.0152486.t003){ref-type="table"}, Model 1), LTL ranked 7th in Costa Rica, 10th in Taiwan, and 9th in the U.S. ([Fig 1](#pone.0152486.g001){ref-type="fig"}). LTL was somewhat better than random chance in discriminating between decedents and survivors: AUC = 0.59 in Costa Rica; 0.57 in Taiwan; 0.58 in the U.S. ([Table 2](#pone.0152486.t002){ref-type="table"}). In addition to age, several self-reported variables and the cognitive assessment were stronger predictors of mortality than LTL. Among the eight biomarkers, LTL ranked second in Costa Rica, fourth in Taiwan, and third in the U.S. Body mass index (inversely associated with mortality) ranked higher than LTL in all countries, while serum creatinine outperformed LTL in two of the three countries. With the exception of LTL, the biomarkers tested here represent clinical markers commonly used in treatment decisions. Yet, five of the eight biomarkers offered weak discrimination (AUC\<0.60) in all three countries.

![AUC for 22 Potential Predictors of Five-Year Mortality.\
(A) Costa Rica. (B) Taiwan. (C) U.S. Only the top 10 predictors are labeled. Abbreviations: ADL, Activities of daily living; AUC, Area under the receiver-operating-characteristic curve; BMI, Body Mass Index; CRP, C-reactive protein; DBP, Diastolic blood pressure; LTL, Leukocyte telomere length; SAH, Self-assessed health status; SCr, Serum creatinine.](pone.0152486.g001){#pone.0152486.g001}

10.1371/journal.pone.0152486.t002

###### AUC and Rank for 22 Potential Predictors of All-Cause Mortality, by Country.
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                                  Costa Rica (*N =* 923)   Taiwan (*N =* 976)   U.S. (*N =* 2672)                
  ------------------------------- ------------------------ -------------------- ------------------- ---- ------- ----
  Age                             0.776                    1                    0.744               1    0.714   1
  Sex                             0.536                    18                   0.520               20   0.557   14
  Marital status                  0.632                    6                    0.625               4    0.551   17
  Education                       0.564                    13                   0.591               7    0.56    11
  Social integration              0.538                    17                   0.558               14   0.557   13
  Smoking status                  0.566                    11                   0.555               16   0.548   19
  Exercise frequency              0.582                    9                    0.522               19   0.600   7
  Self-assessed health status     0.534                    19                   0.578               9    0.618   6
  Number of ADL limitations       0.676                    4                    0.555               15   0.633   5
  Index of mobility limitations   0.727                    2                    0.671               3    0.674   2
  History of diabetes             0.524                    20                   0.562               12   0.534   22
  History of cancer               0.508                    22                   0.502               22   0.546   20
  Number of hospital days/stays   0.546                    15                   0.554               17   0.556   15
  Cognitive function              0.723                    3                    0.679               2    0.662   3
  Systolic blood pressure         0.564                    12                   0.558               13   0.555   16
  Diastolic blood pressure        0.585                    8                    0.511               21   0.576   10
  Total cholesterol               0.540                    16                   0.568               11   0.549   18
  Glycosylated hemoglobin         0.514                    21                   0.535               18   0.537   21
  Body mass index                 0.633                    5                    0.583               8    0.589   8
  C-reactive protein              0.554                    14                   0.619               5    0.559   12
  Serum creatinine                0.578                    10                   0.611               6    0.654   4
  Leukocyte telomere length       0.593                    7                    0.570               10   0.580   9

10.1371/journal.pone.0152486.t003

###### Hazard ratios (HR) and gain in AUC attributable to LTL and selected best predictors of all-cause mortality.

CRELES (Costa Rica, N = 923), SEBAS (Taiwan, N = 976), and NHANES (U.S., N = 2672).
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                                                                                                  HR[^a^](#t003fn007){ref-type="table-fn"}        Gain in AUC[^b^](#t003fn008){ref-type="table-fn"}                                                                                                                                              
  ----------------------------------------------------------------------------------------------- ----------------------------------------------- ----------------------------------------------------------------------------------------- ----------------------------------------------- ---------------------------------------- ----------- -----------
  **Model 1: Unadjusted**                                                                                                                                                                                                                                                                   *vs*. *Random Chance (AUC = 0*.*50)*                 
   a) LTL                                                                                         0.77[\*\*\*](#t003fn004){ref-type="table-fn"}   0.82[\*](#t003fn002){ref-type="table-fn"}                                                 0.70[\*\*\*](#t003fn004){ref-type="table-fn"}   0.093                                    0.070       0.080
   b) Age                                                                                         2.40[\*\*\*](#t003fn004){ref-type="table-fn"}   2.41[\*\*\*](#t003fn004){ref-type="table-fn"}                                             4.94[\*\*\*](#t003fn004){ref-type="table-fn"}   **0.276**                                **0.244**   **0.214**
   c) Self-Reported Mobility                                                                      2.13[\*\*\*](#t003fn004){ref-type="table-fn"}   1.79[\*\*\*](#t003fn004){ref-type="table-fn"}                                             1.71[\*\*\*](#t003fn004){ref-type="table-fn"}   0.227                                    0.171       0.174
   d) Cognitive Function                                                                          0.65[\*\*\*](#t003fn004){ref-type="table-fn"}   0.59[\*\*\*](#t003fn004){ref-type="table-fn"}                                             0.63[\*\*\*](#t003fn004){ref-type="table-fn"}   0.223                                    0.179       0.162
   e) ADL limitations                                                                             1.76[\*\*\*](#t003fn004){ref-type="table-fn"}   1.25[\*\*\*](#t003fn004){ref-type="table-fn"}                                             1.39[\*\*\*](#t003fn004){ref-type="table-fn"}   0.176                                    0.055       0.133
  **Model 2: Adjusted for age**                                                                                                                                                                                                                                                             *vs*. *Age only*                                     
   a) LTL                                                                                         1.05                                            0.93                                                                                      0.85[\*](#t003fn002){ref-type="table-fn"}       \<0.001                                  \<0.001     0.006
   b) Self-Reported Mobility                                                                      1.45[\*\*\*](#t003fn004){ref-type="table-fn"}   1.35[\*\*](#t003fn003){ref-type="table-fn"}                                               1.53[\*\*\*](#t003fn004){ref-type="table-fn"}   **0.017**                                0.013       0.036
   c) Self-Assessed Health (SAH)                                                                                                                                                                                                                                                            0.004                                    **0.020**   **0.042**
    Poor (ref)                                                                                    1.00                                            1.00                                                                                      1.00                                                                                                 
    Fair                                                                                          1.06                                            0.34[\*\*](#t003fn003){ref-type="table-fn"}                                               0.42[\*\*\*](#t003fn004){ref-type="table-fn"}                                                        
    Good                                                                                          0.90                                            0.37[\*\*](#t003fn003){ref-type="table-fn"}                                               0.30[\*\*\*](#t003fn004){ref-type="table-fn"}                                                        
    Very Good                                                                                     0.61[+](#t003fn001){ref-type="table-fn"}        0.31[\*\*](#t003fn003){ref-type="table-fn"}                                               0.21[\*\*\*](#t003fn004){ref-type="table-fn"}                                                        
    Excellent                                                                                     0.89                                            0.17[\*\*\*](#t003fn004){ref-type="table-fn"}                                             0.19[\*\*\*](#t003fn004){ref-type="table-fn"}                                                        
   d) Cognitive Function                                                                          0.84[\*](#t003fn002){ref-type="table-fn"}       0.73[\*\*\*](#t003fn004){ref-type="table-fn"}                                             0.66[\*\*\*](#t003fn004){ref-type="table-fn"}   0.008                                    0.016       0.026
  **Model 3: Adjusted for age and sex**                                                                                                                                                                                                                                                     *vs*. *Age and Sex only*                             
   a) LTL                                                                                         1.07                                            0.92                                                                                      0.88[+](#t003fn001){ref-type="table-fn"}        0.001                                    \<0.001     0.002
   b) Self-Reported Mobility                                                                      1.51[\*\*\*](#t003fn004){ref-type="table-fn"}   1.45[\*\*\*](#t003fn004){ref-type="table-fn"}                                             1.60[\*\*\*](#t003fn004){ref-type="table-fn"}   **0.021**                                0.014       0.038
   c) Self-Assessed Health Status                                                                                                                                                                                                                                                           0.004                                    **0.018**   **0.039**
    Poor (ref)                                                                                    1.00                                            1.00                                                                                      1.00                                                                                                 
    Fair                                                                                          1.04                                            0.34[\*\*](#t003fn003){ref-type="table-fn"}                                               0.42[\*\*\*](#t003fn004){ref-type="table-fn"}                                                        
    Good                                                                                          0.89                                            0.36[\*\*](#t003fn003){ref-type="table-fn"}                                               0.31[\*\*\*](#t003fn004){ref-type="table-fn"}                                                        
    Very Good                                                                                     0.61[+](#t003fn001){ref-type="table-fn"}        0.31[\*\*](#t003fn003){ref-type="table-fn"}                                               0.21[\*\*\*](#t003fn004){ref-type="table-fn"}                                                        
    Excellent                                                                                     0.89                                            0.16[\*\*\*](#t003fn004){ref-type="table-fn"}                                             0.19[\*\*\*](#t003fn004){ref-type="table-fn"}                                                        
   d) Cognitive Function                                                                          0.84[\*](#t003fn002){ref-type="table-fn"}       0.71[\*\*\*](#t003fn004){ref-type="table-fn"}                                             0.67[\*\*\*](#t003fn004){ref-type="table-fn"}   0.008                                    0.015       0.021
   e) ADL limitations                                                                             1.30[\*\*\*](#t003fn004){ref-type="table-fn"}   1.12[\*](#t003fn002){ref-type="table-fn"}                                                 1.30[\*\*\*](#t003fn004){ref-type="table-fn"}   0.012                                    0.007       0.026
   f) CRP                                                                                         1.23[\*\*\*](#t003fn004){ref-type="table-fn"}   1.42[\*\*\*](#t003fn004){ref-type="table-fn"}^,^ [^c^](#t003fn009){ref-type="table-fn"}   1.09[\*\*\*](#t003fn004){ref-type="table-fn"}   0.010                                    0.017       0.007
    CRP x Age                                                                                     \--                                             0.99[+](#t003fn001){ref-type="table-fn"}                                                  \--                                                                                                  
  **Model 4: Adjusted for all sociodemographic controls**[^d^](#t003fn010){ref-type="table-fn"}                                                                                                                                                                                             *vs*. *Sociodemographic controls only*               
   a) LTL                                                                                         1.06                                            0.94                                                                                      0.88[+](#t003fn001){ref-type="table-fn"}        \<0.001                                  \<0.001     0.002
   b) Self-Reported Mobility                                                                      1.48[\*\*\*](#t003fn004){ref-type="table-fn"}   1.41[\*\*](#t003fn003){ref-type="table-fn"}                                               1.57[\*\*\*](#t003fn004){ref-type="table-fn"}   **0.018**                                0.011       **0.032**
   c) Self-Assessed Health Status                                                                                                                                                                                                                                                           0.005                                    0.012       0.031
    Poor (ref)                                                                                    1.00                                            1.00                                                                                      1.00                                                                                                 
    Fair                                                                                          1.04                                            0.38[\*\*](#t003fn003){ref-type="table-fn"}                                               0.43[\*\*\*](#t003fn004){ref-type="table-fn"}                                                        
    Good                                                                                          0.82                                            0.41[\*\*](#t003fn003){ref-type="table-fn"}                                               0.31[\*\*\*](#t003fn004){ref-type="table-fn"}                                                        
    Very Good                                                                                     0.58[+](#t003fn001){ref-type="table-fn"}        0.33[\*\*](#t003fn003){ref-type="table-fn"}                                               0.21[\*\*\*](#t003fn004){ref-type="table-fn"}                                                        
    Excellent                                                                                     0.82                                            0.21[\*\*](#t003fn003){ref-type="table-fn"}                                               0.20[\*\*\*](#t003fn004){ref-type="table-fn"}                                                        
   d) Cognitive Function                                                                          0.81[\*](#t003fn002){ref-type="table-fn"}       0.76[\*\*](#t003fn003){ref-type="table-fn"}                                               0.66[\*\*\*](#t003fn004){ref-type="table-fn"}   0.006                                    0.008       0.013
   e) ADL limitations                                                                             1.30[\*\*\*](#t003fn004){ref-type="table-fn"}   1.13[\*](#t003fn002){ref-type="table-fn"}                                                 1.29[\*\*\*](#t003fn004){ref-type="table-fn"}   0.010                                    0.004       0.025
   f) CRP                                                                                         1.24[\*\*\*](#t003fn004){ref-type="table-fn"}   1.52[\*\*](#t003fn003){ref-type="table-fn"}                                               1.08[\*\*\*](#t003fn004){ref-type="table-fn"}   0.007                                    **0.017**   0.006
    CRP x Age                                                                                     \--                                             0.99[\*](#t003fn002){ref-type="table-fn"}                                                 \--                                                                                                  

^+^ *p* \< 0.10,

\* *p* \< 0.05,

\*\* *p* \< 0.01,

\*\*\* *p* \< 0.001,

two-tailed.

Note: The best predictor of mortality for a given model in the specified country is indicated with bold type.

^a^ With the exception of self-assessed health status and education, the HR represents the effect per SD of the specified predictor.

^b^ Change in the AUC is based on a comparison between a model that includes the specified predictor with one that excludes that predictor.

^c^ The effect of the predictor varied with age; the main effect represents the HR at age 54.

^d^ In addition to age and sex, sociodemographic control variables include race/ethnicity (except in Costa Rica were race/ethnicity was not asked because 90% of the population is white/mestizo), marital status, and educational attainment.

In order to account for sampling design, the models for Taiwan also included urban residence and the models for Costa Rica included residence in the Nicoya region.

The next set of models controlled for age and again included each of the remaining predictors individually. LTL fell to 17th place in Costa Rica, 21st in Taiwan, and 16th in the U.S. (out of 21). Net of age, the incremental contribution of LTL was substantially smaller (ΔAUC\<0.007) than the contributions of the best predictor in each country: self-reported mobility in Costa Rica (ΔAUC = 0.017) and self-assessed health status in Taiwan (ΔAUC = 0.02) and U.S. (ΔAUC = 0.042; [Table 3](#pone.0152486.t003){ref-type="table"}, Model 2). Self-reported mobility was among the top five predictors of mortality in all three countries.

Because LTL is strongly correlated with both age and sex \[[@pone.0152486.ref021], [@pone.0152486.ref022]\], we ran a final set of models that adjusted for both age and sex. LTL still ranked low (15th in Costa Rica, 17th in Taiwan and the U.S.; [Fig 2](#pone.0152486.g002){ref-type="fig"}) and its incremental contribution was very small (ΔAUC\<0.002; [Table 4](#pone.0152486.t004){ref-type="table"}). Net of age and sex, 13 variables were more powerful predictors of mortality than LTL in all three countries: 10 self-reported (mobility, self-assessed health status, ADL limitations, cognitive function, smoking, exercise, hospital stays/days, marital status, education, and social integration) and 3 biomarkers (C-reactive protein, serum creatinine, and glycosylated hemoglobin). Self-reported mobility was consistently one of the best prognostic measures, ranking 1st in Costa Rica (ΔAUC = 0.021), 2nd in the United States (ΔAUC = 0.038), and 4th in Taiwan (ΔAUC = 0.014).

![Gain in AUC for 20 Potential Predictors of Five-Year Mortality After Adjustment for Age and Sex.\
(A) Costa Rica. (B) Taiwan. (C) U.S. Only the top 10 predictors and LTL are labeled. Abbreviations: ADL, Activities of daily living; AUC, Area under the receiver-operating-characteristic curve; CRP, C-reactive protein; HbA1c, Glycosylated hemoglobin; SAH, Self-assessed health status; SCr, Serum creatinine.](pone.0152486.g002){#pone.0152486.g002}

10.1371/journal.pone.0152486.t004

###### Gain in AUC after adjustment for age and sex for 20 potential predictors of all-cause mortality, by country.

![](pone.0152486.t004){#pone.0152486.t004g}

                                  Costa Rica (*N =* 923)   Taiwan (*N =* 976)   U.S. (*N =* 2672)                
  ------------------------------- ------------------------ -------------------- ------------------- ---- ------- ----
  Marital status                  0.006                    10                   0.006               11   0.008   10
  Education                       0.002                    13                   0.009               7    0.007   13
  Social integration              0.002                    14                   0.003               15   0.004   14
  Smoking status                  0.009                    7                    0.006               10   0.016   6
  Exercise frequency              0.006                    9                    0.005               13   0.020   5
  Self-assessed health status     0.004                    11                   0.018               1    0.039   1
  Number of ADL limitations       0.012                    2                    0.007               9    0.026   3
  Index of mobility limitations   0.021                    1                    0.014               4    0.038   2
  History of diabetes             0.000                    19                   0.010               6    0.011   7
  History of cancer               0.000                    20                   0.000               19   0.003   15
  Number of hospital days/stays   0.011                    3                    0.006               12   0.010   9
  Cognitive function              0.008                    8                    0.015               3    0.021   4
  Systolic blood pressure         0.000                    16                   0.000               18   0.001   18
  Diastolic blood pressure        0.003                    12                   0.001               16   0.001   20
  Total cholesterol               0.000                    18                   0.004               14   0.001   19
  Glycosylated hemoglobin         0.009                    6                    0.007               8    0.008   11
  Body mass index                 0.000                    17                   -0.001              20   0.002   16
  C-reactive protein              0.010                    4                    0.017               2    0.007   12
  Serum creatinine                0.009                    5                    0.011               5    0.010   8
  Leukocyte telomere length       0.001                    15                   0.000               17   0.002   17

Robustness to Alternative Specifications {#sec009}
----------------------------------------

Because the onset of cellular senescence is triggered by the shortest telomeres \[[@pone.0152486.ref053]\], LTL may have a non-linear association with mortality. When we categorized LTL and the other biomarkers into quintiles, the results remained similar (see [S1](#pone.0152486.s004){ref-type="supplementary-material"}, [S2](#pone.0152486.s005){ref-type="supplementary-material"} and [S3](#pone.0152486.s006){ref-type="supplementary-material"} Figs, Panel B). Net of age and sex, LTL still yielded a small improvement in discrimination (ΔAUC\<0.005) in all countries. We found no evidence of a non-linear relationship between average LTL and mortality.

Some have suggested that the association between LTL and mortality may be stronger at younger ages \[[@pone.0152486.ref021], [@pone.0152486.ref054]\]. We explored this hypothesis using all respondents 20 and older for whom LTL was assayed in the U.S. (*N =* 7822; data from Costa Rica and Taiwan did not include younger individuals). We found no evidence that the effect of LTL on mortality varied significantly by age, whether we treated age as linear or categorical: 20--59, 60--74, 75--84, 85+ (see [S2 Appendix](#pone.0152486.s002){ref-type="supplementary-material"} and [S3 Table](#pone.0152486.s012){ref-type="supplementary-material"}). The findings based on respondents 20 and older ([S4 Fig](#pone.0152486.s007){ref-type="supplementary-material"}, Panel A) were similar to those presented here. This consistency results largely from the small number of deaths between ages 20 and 59, many of which result from external causes.

The strength of LTL as a mortality predictor may also vary by length of follow-up. For example, among people who are critically ill, LTL might be inflated because of a shift in the distribution of leukocyte subtypes (e.g., an increase in the proportion of neutrophils, which tend to have longer telomere length than lymphocytes \[[@pone.0152486.ref055]\]). An increase in LTL just prior to death would weaken the relationship with short-term mortality. It is also plausible that LTL is a stronger predictor of long-term than short-term mortality because telomere length reflects the gradual process of cellular aging. However, our tests for non-proportional hazards showed no evidence that the effect of LTL varied by duration of follow-up in any country. When we excluded deaths within one year after LTL measurement (*N =* 64 in CRELES, *N =* 15 in SEBAS, and *N =* 55 in NHANES) and modeled the association between LTL and mortality from one to five years post-exam, LTL ranked lower relative to the other predictors. After extending the follow-up period to include all available data (mean 6.6 years for CRELES, 11.2 years for SEBAS, and 9.9 years for NHANES) and including all U.S. respondents aged 20 and older, we found that LTL contributed a negligible improvement in the AUC (\<0.001) net of age and sex. In sum, we found little evidence that the association between LTL and mortality differed by length of follow-up.

Next, we re-estimated the models adjusting for a broader set of sociodemographic control variables, including race/ethnicity, marital status, and education. The results were essentially unchanged: LTL still ranked low and the incremental improvement in the AUC net of age and sex remained very small ([Table 3](#pone.0152486.t003){ref-type="table"}, Model 4 and [S1](#pone.0152486.s004){ref-type="supplementary-material"}, [S2](#pone.0152486.s005){ref-type="supplementary-material"} and [S3](#pone.0152486.s006){ref-type="supplementary-material"} Figs, Panel C).

Finally, results from a similar set of models using cause-specific mortality (i.e., cardiovascular disease, cancer, and all other causes combined; see [S2 Appendix](#pone.0152486.s002){ref-type="supplementary-material"} and [S4 Table](#pone.0152486.s013){ref-type="supplementary-material"}) as the outcome were consistent with those presented here for all-cause mortality. Net of age and sex, LTL yielded a negligible improvement in the AUC and ranked well below many other predictors ([S5 Table](#pone.0152486.s014){ref-type="supplementary-material"} and [S4](#pone.0152486.s007){ref-type="supplementary-material"}, [S5](#pone.0152486.s008){ref-type="supplementary-material"} and [S6](#pone.0152486.s009){ref-type="supplementary-material"} Figs).

Discussion {#sec010}
==========

Technological advances allow us to measure intricate details about human physiology. Yet, to prove its worth, a novel biomarker should tell us more than we already know based on simpler observables. The biological processes of telomere shortening and subsequent cell senescence suggest potentially strong linkages between telomere length, aging, and survival. Previous efforts that have identified statistically significant linkages between telomere length and mortality seemingly provide some support for this expectation. However, prior to our analysis, the discriminatory ability of telomere length relative to well-established variables in the social and health sciences had never been evaluated.

Consistent with several studies that examined the relationship between LTL and five-year all-cause mortality, we found a significant hazard ratio in an unadjusted model, although the effect size was modest and was largely attenuated after controlling for age ([Table 3](#pone.0152486.t003){ref-type="table"}). More importantly for the purpose of prognosis, we found that LTL had little discriminatory ability and under-performed many conventional predictors of mortality, including easily collected self-reported measures. Indeed, 13 variables were more powerful predictors of mortality than LTL in all three countries. The self-reported measure of mobility limitations was consistently one of the strongest predictors of all-cause mortality. Given that strong mortality predictors are almost certainly proxies for myriad factors accumulated over a lifetime, the subjective nature of self-reports has the advantage of capturing perceptions that may integrate complex information.

The weak contribution of LTL may result, at least in part, from the difficulty of measurement. There is notable measurement error in LTL analysis resulting from various sources including DNA quality and within- and between-well and -plate error \[[@pone.0152486.ref056]\]. In addition, normal day-to-day variation in LTL represents noise that reduces statistical power to isolate the underlying signal \[[@pone.0152486.ref057]\]. Random variation---whether it results from measurement error or other factors---will lead to attenuation bias. If non-systematic error is greater for LTL than for other variables, it would reduce the relative ranking of LTL. Importantly, the inter-assay coefficient of variation of the three studies reported here ranges from 4 to 7%, which is on the lower end of the reported variation for Q-PCR telomere length assays \[[@pone.0152486.ref056]\].

A further limitation is that this study evaluates only a one-time measurement of LTL. We do not have the data to quantify individual-level changes in LTL over time for all three datasets, and thus cannot assess whether the rate of telomere shortening might provide more prognostic power. One important challenge in estimating the effects of LTL attrition is that measurement error becomes a much bigger problem. If there is substantial measurement error, the apparent change in LTL may reflect more noise than signal, and statistical power would be severely compromised.

An additional concern is that our analysis is limited to telomere length in leukocytes, which may not reflect telomere length in other tissues. Although telomere lengths from various tissues are well-correlated \[[@pone.0152486.ref001]\], that may not hold across all tissue types. Furthermore, the distribution of leukocyte (white blood cell, WBC) subtypes may affect measures of LTL because the Q-PCR technique yields a weighted average across a mix of different cell types. Although highly correlated, different WBC subsets have different telomere lengths \[[@pone.0152486.ref055], [@pone.0152486.ref058], [@pone.0152486.ref059]\]. However, Glei et al. \[[@pone.0152486.ref007]\] showed that controlling for WBC distribution had little effect on the association between LTL and mortality.

Evidence suggests that it is the shortest telomeres, rather than average telomere length, that determine the onset of cellular senescence \[[@pone.0152486.ref053]\]. Using the Terminal Restriction Fragment method, Kimura et al. \[[@pone.0152486.ref037]\] found that the average length of the shortest telomeres was a better predictor of mortality than the overall average LTL. Unfortunately, the Q-PCR technique used to assay LTL in our study does not provide information about the distribution of telomere lengths.

The finding that LTL is a weak predictor of mortality in the general population might be explained in part by competing risks. Both extrinsic risk factors and other intrinsic processes may lead to death long before they lead to substantial telomere shortening. The association between LTL and mortality may appear stronger in healthy subpopulations where many competing risks are dormant. However, in exploratory analyses that excluded respondents who reported poor or fair health, the increase in AUC attributable to LTL continued to be very small (results not shown).

Finally, we have evaluated LTL and the other variables *only* in terms of their ability to predict mortality. This constraint entails two important limitations. First, while LTL is not a strong predictor of mortality among older people, it could be a valuable marker of healthspan or of particular aging-related diseases. LTL has been associated with multiple diseases of aging, with the strongest associations for coronary heart disease \[[@pone.0152486.ref060]\]. One study reported that short LTL was associated with fewer years of healthy life, but not with shorter lifespan, supporting the notion that LTL might be a biomarker of healthy aging, but not a biomarker of survival \[[@pone.0152486.ref031]\]. However, our auxiliary analyses of cause-specific mortality (i.e., cardiovascular, cancer, and all other causes combined) suggest that LTL does not perform well against other predictors. Second, the best predictors do not necessarily have causal effects on mortality; they may not represent root causes that can be modified or treated to lower the risk of premature mortality. Nevertheless, accurate prognosis is important when patients and their doctors weigh the risks and benefits of a given treatment.

We find that the molecular clock is nowhere near as powerful as chronological age when it comes to predicting five-year mortality---at least among older humans. Net of age and sex, numerous variables were better predictors of mortality than LTL including self-reported mobility, self-assessed health status, an assessment of cognitive function, smoking, exercise, an inflammatory marker (C-reactive protein), and a marker of kidney function (serum creatinine). Although LTL may eventually help scientists understand aging, more powerful and more easily obtained tools are available for predicting survival.
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